A 17 week, investigator-initiated, single-center, double-blind, randomized, placebo-controlled, cross-over trial of pregabalin in essential tremor

Trial Profile

A 17 week, investigator-initiated, single-center, double-blind, randomized, placebo-controlled, cross-over trial of pregabalin in essential tremor

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Nov 2015

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Essential tremor
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Oct 2009 Results published in the Journal of the Neurological Sciences.
    • 07 Jun 2009 Results presented at the 13th International Congress of Parkinson's Disease and Movement Disorders.
    • 07 Jun 2009 Primary endpoint 'Tremor Clinical Rating Scale' has not been met according to results presented at the 13th International Congress of Parkinson's Disease and Movement Disorders.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top